克罗格于2024年10月4日完成其专业药房业务的出售，售价为4.64亿美元。此次出售使公司第三季度的总销售额比去年同期减少了大约3.4亿美元，预计未来年度销售将减少约30亿美元。KSP是一项低利润业务，其出售提高了克罗格的毛利率以及以销售为比率的经营、一般和管理成本，对营业利润没有实质性影响。
以上内容来自Benzinga Earnings专栏，原文如下：
Sale of Kroger Specialty Pharmacy
Kroger closed the sale of its specialty pharmacy business on October 4, 2024, for $464 million. The sale reduced total company sales in the third quarter by approximately $340 million, compared to the same period last year, and annualized sales will be approximately $3 billion lower going forward. KSP was a low margin business. As a result, the sale of the business increased both Kroger's gross margin and operating, general and administrative costs as a rate of sales. It had no material effect on operating profit.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。